Member Info for riverbliss

Who's panic selling at these prices and at a large discount? As Robina said, history has rewarded investors that have taken the long view on this trust and purchased at historically wide discounts (now probably approaching 18%). It's not comfortable seeing a paper loss, but I've been gradually accumulating BRSC for this year's ISA. There will be a large rebound at some point for patient holders, and I really like the long track record of dividend growth.

I might be joining you in topping up. Never thought I'd see the share price back where it was before the vaccine rally of late 2020! I know there are plenty of headwinds such as cost inflation and squeezed household income - but the shares now represent excellent value for anyone prepared to see beyond the immediate horizon. I wouldn't be surprised if this doubled in value in a few year's time.

Good choice YamR1man, very well-run company with solid prospects and a huge addressable market. I'm sure you'll be pleased looking back in a few years time. It's one of my largest holdings - slightly boring to traders no doubt, but the kind of easily understandable company providing essential things that can make an excellent long-term investment.

Easy way to lose money!
Feel for those investors who got sucked into the dead cat bounce, now down another 40% since steep drop at the end of January. For people thinking this is easy money, just look at how long it took the share to recover after the GFC. Are you really prepared to hold for years on the hope of a sustained recovery. Better to steer well clear of a company with zero margins and pricing power during a period of high inflation. The easy money is in undervalued companies that will benefit in this new environment.

The Diageo SP had a really good run in 2021, justifiably based on strong recovery. However, it perhaps got ahead of itself and is now trading above its recent historic average earnings multiple, at a time when consumers purchasing power is likely to be eroded by high inflation. Still a good long-term hold, but can see this trading sideways or slightly dipping for a period.

I wouldn't be surprised to see it drop even further at this rate, what a complete tank job! This was meant to be a slow and steady growth share but behaving like some speculative AIM biotech/miner. Too late to sell now. Holders will have to console themselves that the shape of the underlying business is good (the most important thing) and hope that supply chain disruption and inflation peak soon.

NASDAQ and S&P500 have recovered strongly from initial losses. There seems to be some sustained buying pressure. I'm going to top up on SMT in the morning, and would anticipate a good rise. Almost certain to be further volatility and dips but this is now at an attractive discount.

Are you able to expand on that Waltz, perhaps with a link to any news? Do you think that's the reason for the sharp sell-off? I am scratching my head because I always assumed this was a slow and steady share, but it's being hammered like its a small-cap, growth, high PE one.

The recent dives in the share price are concerning, it seems to be taking another leg down after stabilising since the sharp fall in September/October. Can't work out whether this is a buying opportunity or time to hold tight - or whether it is stock-specific or general market rotation away from small-cap growth. It's strange because Strix isn't overvalued (I would agree indeed that it's undervalued) with a P/E of under 20 and a 3% dividend and solid growth prospects. Let's wait for the trading update, and hope for some stabilisation or bounce.

Glad I decided to sell out - woeful performance over the past two years from a trust that is supposed to offer 'defensive growth'.

There's no underlying reason for the share price slide. Just general market rotation out of high quality/highly valued shares that have shot up recently (same with SPX, CRDA, HLMA and DPH). I'm initiating a position here and trying to average down by buying in chunks. Experian is not some speculative tech stock. It's a profitable business doing essential tasks with very solid long-term growth prospects. It will be back up at some point.

I don't like this statement, there is very little transparency. The operating loss was apparently down to R&D amortisation costs and 'exceptional non-cash foreign exchange'. It sounds like delays and poor reception around their releases of the Elite Dangerous and Lemnis Gate titles have come back to bit them in terms of additional costs. Not a great sign! I've gone off this company, there is little transparency or visibility over revenues, which leaves it vulnerable to missing financial targets and being derated. It's still a great company, but perhaps not such a great investment as everyone thought. TM17 and KWS far safer ways of capturing the growth in the video games sector in my opinion.

@Investor0109. I agree with you. The chart is showing strong support levels in the low to mid 70s, and that was from May and July 2021, since which the company has made a successful earnings-enhancing acquisition and shown solid forward momentum. I'm looking to top up my holding around here. Great buy in point for new investors too.

Like one of its devices, SPX really needed to have some steam released from its share price and earnings multiple. P/E of nearly 60 completely unsustainable, even though this has great earnings momentum and still solid long-term prospects. I'm just looking for a decent buy-in point..... hopefully coming soon!

Just wondered what the appeal of this trust is to those who hold? Although Train has a good long-term record, the short-term performance of the trust has been poor, with the NAV having having stood still for around 2.5 years, despite very wild fluctuations in the share price and premium/discount (of up to 40%). Is this trust really worth its premium? Must admit, I've never got my head around the massive weighting to Lindsell Train Ltd - and whether this is a benefit or disbenefit?

Downward share price drift makes this seem attractive. I intend to make another top up again if it goes below 90p. It's being caught up in the general negative sentiment around hospitality and fears over the new virus strain. There are certainly headwinds, but City Pub Group has an asset-backed freehold estate (unlike many of its larger competitors) in prosperous locations that benefit from a good customer mix (locals, office workers, students and tourists). They've also got a growing accommodation offering (as demonstrated by the recent purchase of the Cliftonville Hotel in Cromer). The quality of the estate, diversity of revenue sources and focused management, in my view, make the upside on CPC greater than other operators. It's also an attractive take-over target whenever Clive Watson decides it's time to exit.

It's not just DODT, the mood music has really changed with these small-cap growth stocks. Whereas, for much of this year they were riding the crest of optimism given favourable financial comparables to the previous year - now any slight reduction in forecasts or margins, and they are being punished with sharp share price falls. The steeper the climb, the harder the falls - we just have to accept this volatility as investors. If we can't deal with it, we should be in cash or bonds. I'm definitely hanging onto my DODT shares, a quality company in a growing sector should be a great long-term investment.

Effectively profits will be wiped out for this year. Whilst most investors probably understand the causes, the thing that has added to nerves is the fact that the directors have dumped virtually all of their shares over the last year. Particularly, CEO Paul Fineman who has sold millions worth of shares and now has virtually no ownership. You should always be suspicious of companies where management are not personally invested in the success of their business. Let's wait and see if any decent director buys, which may restore some damaged confidence to investors.

Trading update this morning. Like-for-like revenue up 11% in the first half of the year (but less than levels expected and against a very soft backdrop). Supply chain disruption and cost inflation have hit profit margins (no numbers given for this half but guiding for around 2% lower for FY22 with cost pressures likely to continue into FY23. This is concerning for business that generates such low margins and with little pricing power. No quick recovery here, but fundamentals of the business good. Might maybe worth buying, looking away for the short-term and holding in anticipation of a longer-term recovery. However, as always DYOR.

Bizarre sell-off based seemingly on no real news, but jitters over director sales (probably justifiable ones with the forthcoming budget in mind). I've taken this gift as an opportunity to add to what has been (and fully expect will continue to be) an excellent long-term investment. Strix now stands at a very large discount compared to other quality and more highly rated UK engineering companies.